I'm no expert, but I have been studying the stem cell world for a while now, and my son works in the field. IMO, PSTI is on the right track. Placentas is where it is at. I don't have an opinion about management as yet. This is a long-term hold for me in a Roth account, so I am not concerned about trading it. Also, when the world at large finally understands what a game-changer this entire line of therapies is, many of these stocks will boom, IMO. I am buying a couple of them.
News 
Market Data 
Discover 
